WO2008152398A3 - Formulations for inhalation - Google Patents
Formulations for inhalation Download PDFInfo
- Publication number
- WO2008152398A3 WO2008152398A3 PCT/GB2008/002029 GB2008002029W WO2008152398A3 WO 2008152398 A3 WO2008152398 A3 WO 2008152398A3 GB 2008002029 W GB2008002029 W GB 2008002029W WO 2008152398 A3 WO2008152398 A3 WO 2008152398A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inhalation
- formulations
- propellant
- polymer
- optionally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Abstract
A pharmaceutical aerosol formulation comprising an active material coated with a polymer, in combination with a propellant, optionally with other pharmaceutically acceptable excipients.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1123/MUM/2007 | 2007-06-14 | ||
IN1123MU2007 | 2007-06-14 | ||
IN1249/MUM/2007 | 2007-06-29 | ||
IN1249MU2007 | 2007-06-29 | ||
IN1253/MUM/2007 | 2007-07-02 | ||
IN1253MU2007 | 2007-07-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008152398A2 WO2008152398A2 (en) | 2008-12-18 |
WO2008152398A3 true WO2008152398A3 (en) | 2009-11-12 |
Family
ID=39869725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2008/002029 WO2008152398A2 (en) | 2007-06-14 | 2008-06-12 | Formulations for inhalation |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008152398A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0801876D0 (en) | 2008-02-01 | 2008-03-12 | Vectura Group Plc | Suspension formulations |
TR201007251A2 (en) * | 2010-09-01 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Calcium channel blocker formulation. |
TWI597072B (en) | 2011-10-11 | 2017-09-01 | 吉斯藥品公司 | Crystalline microparticles of a beta-agonist coated with a fatty acid |
CA2881158A1 (en) | 2012-07-26 | 2014-01-30 | Wockhardt Limited | Pharmaceutical composition comprising diamorphine for intranasal administration |
US20150250713A1 (en) * | 2012-10-23 | 2015-09-10 | Cipla Limited | Pharmaceutical Composition |
EP3174522A1 (en) | 2014-07-29 | 2017-06-07 | 3M Innovative Properties Company | Method of preparing a pharmaceutical composition |
CN106551909A (en) * | 2015-09-23 | 2017-04-05 | 苏州欧米尼医药有限公司 | A kind of preparation method of high dispersive fine powder granule |
CN110840864B (en) * | 2019-12-20 | 2022-02-22 | 广州健康元呼吸药物工程技术有限公司 | Beta 2 receptor agonist inhalation aerosol and product containing same |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998034596A2 (en) * | 1997-02-07 | 1998-08-13 | Minnesota Mining And Manufacturing Company | Biocompatible compounds for pharmaceutical drug delivery systems |
WO1999038493A1 (en) * | 1998-01-30 | 1999-08-05 | Rtp Pharma Inc. | Microparticle inhalation formulations |
WO2002003958A1 (en) * | 2000-07-11 | 2002-01-17 | Astrazeneca Ab | Novel aerosol formulation containing a polar fluorinated molecule |
WO2003063843A1 (en) * | 2002-02-01 | 2003-08-07 | Astrazeneca Ab | Composition for inhalation |
US6641800B1 (en) * | 1991-09-25 | 2003-11-04 | Fisons Ltd. | Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane |
WO2005056037A1 (en) * | 2003-12-10 | 2005-06-23 | Medpharm Limited | Metered dose inhalation preparations of proteins and peptides |
WO2005055985A1 (en) * | 2003-12-10 | 2005-06-23 | Medpharm Limited | Metered dose inhalation preparations of therapeutic drugs |
-
2008
- 2008-06-12 WO PCT/GB2008/002029 patent/WO2008152398A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6641800B1 (en) * | 1991-09-25 | 2003-11-04 | Fisons Ltd. | Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane |
WO1998034596A2 (en) * | 1997-02-07 | 1998-08-13 | Minnesota Mining And Manufacturing Company | Biocompatible compounds for pharmaceutical drug delivery systems |
WO1999038493A1 (en) * | 1998-01-30 | 1999-08-05 | Rtp Pharma Inc. | Microparticle inhalation formulations |
WO2002003958A1 (en) * | 2000-07-11 | 2002-01-17 | Astrazeneca Ab | Novel aerosol formulation containing a polar fluorinated molecule |
WO2003063843A1 (en) * | 2002-02-01 | 2003-08-07 | Astrazeneca Ab | Composition for inhalation |
WO2005056037A1 (en) * | 2003-12-10 | 2005-06-23 | Medpharm Limited | Metered dose inhalation preparations of proteins and peptides |
WO2005055985A1 (en) * | 2003-12-10 | 2005-06-23 | Medpharm Limited | Metered dose inhalation preparations of therapeutic drugs |
Also Published As
Publication number | Publication date |
---|---|
WO2008152398A2 (en) | 2008-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008152398A3 (en) | Formulations for inhalation | |
WO2008120207A3 (en) | Compositions for nasal delivery | |
WO2006101882A3 (en) | Medicament delivery formulations, devices and methods | |
WO2007135193A3 (en) | Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means | |
WO2012007729A3 (en) | Pharmaceutical compositions comprising r (+) budesonide and one or more bronchodilators | |
WO2009117130A3 (en) | Extended release forumulation containing a wax | |
WO2008109462A3 (en) | Sustained release pellets comprising wax-like material | |
WO2009062746A3 (en) | Topical drugs for use in antifungal therapy | |
WO2010052466A8 (en) | Pharmaceutical aerosol composition | |
WO2010006143A3 (en) | Transdermal estrogen device and delivery | |
WO2009061607A3 (en) | Water-immiscible materials as vehicles for drug delivery | |
WO2006131931A3 (en) | Patch for transdermal drug delivery | |
HK1101346A1 (en) | Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient | |
WO2012022919A3 (en) | Nalbuphine-based formulations and uses thereof | |
WO2008145348A3 (en) | Dispensing device | |
WO2009043049A3 (en) | Pharmaceutical formulations | |
NZ612326A (en) | Biodegradable drug delivery compositions | |
WO2011084618A3 (en) | Compositions and methods for oral drug delivery | |
WO2010027404A3 (en) | Stable formulation comprising therapeutic polypeptides for oral administration | |
WO2010027405A3 (en) | Formulations of gc-c receptor agonist polypeptides | |
WO2007144169A3 (en) | Entacapone-derivatives | |
WO2006008173A3 (en) | Pharmaceutical formulations for inhalation | |
WO2011143118A3 (en) | Alcohol-resistant formulations | |
WO2011076212A3 (en) | Processes for the manufacture of a pharmaceutically active agent | |
WO2012085284A3 (en) | High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08762359 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2342/MUMNP/2009 Country of ref document: IN |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08762359 Country of ref document: EP Kind code of ref document: A2 |